Pfizer’s Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says
April 20 (Reuters) - Pfizer's Chief Strategy and Innovation Officer, Andrew Baum, is transitioning to a new role and will eventually leave the company as part of the U.S. drugmaker's strategic simplification, according to an analyst note on Monday.
Baum, who joined Pfizer in 2024,... Read More.


